Literature DB >> 15207415

Validation of a modified version of the Gijon's social-familial evaluation scale (SFES): the "Barcelona SFES Version", for patients with cognitive impairment.

P Garcia-Caselles1, R Miralles, M Arellano, R M Torres, A Aguilera, M Pi-Figueras, A M Cervera.   

Abstract

The aim was to validate an abbreviated version of the Gijon's social-familial evaluation scale (SFES) (Barcelona-SFES version), on patients with cognitive impairment. A group of 34 patients with cognitive impairment, admitted to an intermediate-long-term-care facility, were analyzed. Mean age was 80.2 +/- 7.4 years. Gijón's SFES was abbreviated and only the first three item groups corresponding to family conditions, social contacts and assistance from the social network were selected. Barcelona-SFES version had a range score between 3 to 15 points, in which low scores identify older patients who live with their family, have good contacts, and participate in community activities. In contrast, high scores identify older persons who live alone and have poor social support and little participation with community activities. Three social risk categories were established according to the Barcelona-SFES score: low social risk (>/= 7 points), intermediate social risk (8-9 points) and high social points). Validation criteria used in the present study were: predictive value of Barcelona-SFES score of post-discharge destination (home or institution), and patient's (or family's) request for a definitive institutionalization in a nursing home. There were 9 patients with low social risk (26.4 %), 8 with intermediate social risk (23.5 %) and 17 with high social risk (50 %). A significant relationship between Barcelona-SFES scores and post-discharge destination was found. Eighty percent of patients discharged to an institution(nursing and residential homes), they had high social risk SFES scores (>/= 10) Also, a significant correlation was found between the number of patients for which a definitive institutionalization request was performed and the Barcelona-SFES scores. Fifteen (88.2 %) of the 18 patients for whom the request was done, were in the high social risk group. The lowest scores from SFES were predictive of home discharge, while the highest scores were predictive of a definitive institutionalization.

Entities:  

Mesh:

Year:  2004        PMID: 15207415     DOI: 10.1016/j.archger.2004.04.028

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr Suppl        ISSN: 0924-7947


  9 in total

1.  Quality of Life in Older Patients after a Heart Failure Hospitalization: Results from the SENECOR Study.

Authors:  Daniele Luiso; Marta Herrero-Torrus; Neus Badosa; Cristina Roqueta; Sonia Ruiz-Bustillo; Laia C Belarte-Tornero; Sandra Valdivielso-Moré; Ronald O Morales; Olga Vázquez; Núria Farré
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

2.  Exploring the use of assistive products to promote functional independence in self-care activities in the bathroom.

Authors:  Iván De-Rosende-Celeiro; Gabriel Torres; Mercedes Seoane-Bouzas; Adriana Ávila
Journal:  PLoS One       Date:  2019-04-08       Impact factor: 3.240

3.  Evaluation Design of EFFICHRONIC: The Chronic Disease Self-Management Programme (CDSMP) Intervention for Citizens with a Low Socioeconomic Position.

Authors:  Siok Swan Tan; Marta M Pisano; An Ld Boone; Graham Baker; Yves-Marie Pers; Alberto Pilotto; Verushka Valsecchi; Sabrina Zora; Xuxi Zhang; Irene Fierloos; Hein Raat
Journal:  Int J Environ Res Public Health       Date:  2019-05-28       Impact factor: 3.390

4.  EFFICHRONIC study protocol: a non-controlled, multicentre European prospective study to measure the efficiency of a chronic disease self-management programme in socioeconomically vulnerable populations.

Authors:  An L D Boone; Marta M Pisano-Gonzalez; Verushka Valsecchi; Siok Swan Tan; Yves-Marie Pers; Raquel Vazquez-Alvarez; Delia Peñacoba-Maestre; Graham Baker; Alberto Pilotto; Sabrina Zora; Hein Raat; Jose Ramón Hevia-Fernandez
Journal:  BMJ Open       Date:  2019-12-18       Impact factor: 2.692

5.  Association between Family Functionality and Depression: A Systematic Review and Meta-Analysis.

Authors:  Daniel Guerrero-Muñoz; Diana Salazar; Victoria Constain; Alvaro Perez; Carlos Andrés Pineda-Cañar; Herney Andrés García-Perdomo
Journal:  Korean J Fam Med       Date:  2020-06-10

6.  Depressed Mood after Stroke: Predictive Factors at Six Months Follow-Up.

Authors:  Fidel López-Espuela; Raúl Roncero-Martín; Maria de la Luz Canal-Macías; Jose M Moran; Vicente Vera; Adela Gomez-Luque; Alejandro Lendinez-Mesa; Juan Diego Pedrera-Zamorano; Ignacio Casado-Naranjo; Jesus Lavado-García
Journal:  Int J Environ Res Public Health       Date:  2020-12-20       Impact factor: 3.390

7.  Randomized Controlled Trial Comparing a Multidisciplinary Intervention by a Geriatrician and a Cardiologist to Usual Care after a Heart Failure Hospitalization in Older Patients: The SENECOR Study.

Authors:  Marta Herrero-Torrus; Neus Badosa; Cristina Roqueta; Sonia Ruiz-Bustillo; Eduard Solé-González; Laia C Belarte-Tornero; Sandra Valdivielso-Moré; Olga Vázquez; Núria Farré
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

8.  The chronic disease Self-Management Programme: A phenomenological study for empowering vulnerable patients with chronic diseases included in the EFFICHRONIC project.

Authors:  Dallal Fracso; Gérard Bourrel; Christian Jorgensen; Hélène Fanton; Hein Raat; Alberto Pilotto; Graham Baker; Marta M Pisano; Rosanna Ferreira; Verushka Valsecchi; Yves-Marie Pers; Agnes Oude Engberink
Journal:  Health Expect       Date:  2022-01-10       Impact factor: 3.318

9.  Agreement of a Short Form of the Self-Administered Multidimensional Prognostic Index (SELFY-MPI-SF): A Useful Tool for the Self-Assessment of Frailty in Community-Dwelling Older People.

Authors:  Alberto Cella; Alberto Ferrari; Giuseppe Rengo; Vincenzo Solfrizzi; Nicola Veronese; Matteo Puntoni; Sabrina Zora; Alberto Pilotto; Filippo Fimognari
Journal:  Clin Interv Aging       Date:  2020-03-30       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.